Forus Health
Forus Health is a Bangalore-based medical device company that builds AI-enabled retinal imaging platforms for diabetic retinopathy screening, selling hardware and AI-software solutions to hospitals, eye clinics, and diagnostic centers primarily in India with global expansion underway.
- Company typePrivate
- Founded2010
- HeadquartersBangalore, India
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Forus Health does
Forus Health Private Limited is a Bangalore-based medical device company founded in 2010 that builds AI-enabled retinal imaging platforms for ophthalmic diagnostics, with a primary focus on screening for diabetic retinopathy and other causes of preventable blindness. Its core product is a retinal imaging system that captures fundus images and, as of an October 2024 partnership with Google, integrates Google's AI model for automated diabetic retinopathy screening, enabling point-of-care diagnostics outside traditional specialist settings. The company serves B2B customers including hospitals, eye clinics, and diagnostic centers, particularly in India and other South Asian markets, with a stated ambition to expand globally following the November 2025 acquisition of a 21% stake by Inviga Healthcare Fund.
Forus Health makes money primarily through hardware sales of its retinal imaging devices to healthcare providers, with a layered AI software or platform-licensing component that introduces recurring revenue. Pricing is not publicly disclosed and is handled through enterprise procurement. The company is backed by tier-1 venture and healthcare investors including Accel, Chiratae Ventures, Asian Healthcare Fund, TPG NewQuest (now exited), and Inviga Healthcare Fund, and operates with a lean team of 51-100 employees. Its distribution relies on direct enterprise sales supplemented by strategic technology and investor partnerships intended to extend market reach.
The operating geographies are anchored in South Asia (India), and the company claims a broader global footprint. Leadership comprises co-founders Shyam Vasudeva Rao, Shyam Vasudev, and K. Chandrasekhar, supported by Chief Scientist Timothy Poston and CTO & Head of R&D Venkatakrishnan S, indicating a technology- and research-driven organization. The addressable market—AI-driven retinal screening devices—is projected to grow from $2.2 billion in 2025 to $7.1 billion in 2035 at a 12.6% CAGR, providing a favorable backdrop for the company's expansion strategy.
Forus Health firmographics
Firmographics- Name
- Forus Health
- Legal name
- Forus Health Private Limited
- Website
- https://forushealth.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Forus Health is a Bangalore-based medical device company that builds AI-enabled retinal imaging platforms for diabetic retinopathy screening, selling hardware and AI-software solutions to hospitals, eye clinics, and diagnostic centers primarily in India with global expansion underway.
- Ownership category
- akta.pro rank
Forus Health industry classification
Industry- Product category
- Ophthalmic Diagnostic Devices
- NAICS
- Ophthalmic Goods Manufacturing (339115), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Retinal Imaging & OCT Systems (OCT/OCTA, Fundus Cameras, Fluorescein/ICG Angiography) (HLAHAJAB)
- akta.pro secondary industry
- Visual Field & Functional Vision Testing (Perimetry, ERG/VEP, Contrast Sensitivity) (HLAHAJAC)
Keywords
Where Forus Health is headquartered
LocationHeadquarters
- HQ city
- Bangalore
- HQ country
- India
- HQ region
- Asia
Offices1 record
Markets served
Forus Health business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales
Revenue model
- Medical Device Sales: Sale of AI-powered retinal imaging devices and screening equipment to healthcare providers, hospitals, and eye clinics
- AI Software/Platform Licensing: AI-powered diagnostic software integrated into retinal imaging devices, potentially offered as platform or licensing model
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
Forus Health product offering
Product offeringCore offering
Forus Health develops and sells AI-powered retinal imaging devices used by healthcare providers to screen patients for diabetic retinopathy and other ocular conditions. The platform combines proprietary retinal imaging hardware with AI-driven diagnostic software, including an integration of Google's AI model for diabetic retinopathy screening. The devices enable point-of-care screening in hospitals, eye clinics, and diagnostic centers, particularly in underserved areas.
Product overview
Forus Health offers a unified retinal imaging platform with integrated AI-powered screening capabilities. The core platform combines hardware (retinal imaging devices) with software analytics to enable automated diabetic retinopathy screening. In October 2024, the platform was enhanced through a partnership with Google to integrate Google's AI model for diabetic retinopathy detection. The company operates in the ophthalmic diagnostics sector, serving healthcare providers with accessible solutions for preventable blindness screening.
Differentiator
Problem solved
Functional benefit
Products and services
- Forus Health Retinal Imaging Platform Ophthalmic diagnostics platform combining proprietary retinal imaging hardware (specialized retinal cameras capturing fundus images) with AI-driven diagnostic software for automated detection of diabetic retinopathy and other ocular conditions. Targeted at hospitals, eye clinics, and diagnostic centers for point-of-care screening.
Quantifiable outcome
- Global AI-driven retinal screening device market growing from $2.2B (2025) to $7.1B (2035) at 12.6% CAGR
Companies that use Forus Health
Customer profileSegments2 records
Ideal customer profiles1 record
Forus Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability2 records
Feature2 records
Forus Health partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- GooglecoreForus Health partnered with Google in October 2024 to integrate Google's AI model for diabetic retinopathy screening into Forus's retinal imaging platform. This partnership enhances Forus's AI capabilities for automated screening of diabetic retinopathy, a leading cause of preventable blindness.
Scale indicators4 records
Recent moves5 records
Expansion highlights5 records
Forus Health competitors and assessment
Company assessmentDirect peers
- Digital Diagnostics (IDx): Pioneer in autonomous AI for diabetic retinopathy diagnosis (IDx-DR), offering a direct competitive benchmark in AI-based point-of-care DR screening.
- Remidio Innovative Solutions: India-based ophthalmic device company producing AI-enabled retinal imaging systems (e.g., NM-Slitlamp, 3nethra-like devices), competing with Forus in both Indian and emerging markets.
- Eyenuk: US-based developer of EyeArt, an FDA-cleared autonomous AI system for diabetic retinopathy screening, directly comparable to Forus Health's Google-AI-powered DR screening platform.
- Airdoc: AI-driven retinal image analysis company offering mass screening solutions for systemic and ocular diseases, directly overlapping with Forus's AI retinal screening use case.
Broad incumbents
- ZEISS Medical Technology: Global leader in ophthalmic devices including fundus cameras and OCT systems; competes with Forus in retinal imaging hardware while also integrating AI into its platform.
- Heidelberg Engineering: Established manufacturer of diagnostic imaging devices (Spectralis OCT, fundus imaging) used by retina specialists, representing the incumbent standard Forus is positioning against.
- Topcon Healthcare: Major ophthalmic imaging and healthcare solutions company with AI-enabled fundus and OCT products, including the Harmony/RDOSS DR screening platform — directly relevant to Forus's market.
- Optos (Nikon Healthcare): Provider of ultra-widefield retinal imaging devices used in DR screening and retina specialty clinics, representing a key incumbent in the same end-market as Forus Health.
Emerging players
- 12 Sigma Technologies: AI medical imaging company whose products include AI-based DR detection, positioning it as an emerging competitor in autonomous retinal screening alongside Forus.
- Phelcom Technologies: Brazil-based developer of portable, AI-powered retinal imaging devices (e.g., Eyer) targeting DR screening in underserved settings — directly comparable to Forus's portable, point-of-care screening model.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Forus Health social profiles
Digital presenceForus Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Forus Health leadership team
Management profileNumber of profiles
Profiles4 records
Forus Health funding detail
Funding detailFunding overview
Funding rounds3 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Forus Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Forus Health
What does Forus Health do?
Forus Health develops and sells AI-powered retinal imaging devices used by healthcare providers to screen patients for diabetic retinopathy and other ocular conditions. The platform combines proprietary retinal imaging hardware with AI-driven diagnostic software, including an integration of Google's AI model for diabetic retinopathy screening. The devices enable point-of-care screening in hospitals, eye clinics, and diagnostic centers, particularly in underserved areas.
Is Forus Health a public or private company?
Forus Health is a private company. It is classified as venture growth investor backed and is currently operating.
When was Forus Health founded?
Forus Health was founded in 2010. It employs 51 to 100 people.
Where is Forus Health based?
Forus Health is headquartered in Bangalore, India, in the Asia region.
How does Forus Health make money?
Two revenue lines are on record. Medical Device Sales are the primary driver. The others are AI Software/Platform Licensing.
Who are Forus Health's main competitors?
Direct peers on record are Digital Diagnostics (IDx), Remidio Innovative Solutions, Eyenuk and Airdoc. Broad incumbents are ZEISS Medical Technology, Heidelberg Engineering, Topcon Healthcare and Optos (Nikon Healthcare). Emerging players are 12 Sigma Technologies and Phelcom Technologies.
Does Forus Health have an API?
No public API is recorded for Forus Health.
What industry is Forus Health in?
Forus Health's product category is Ophthalmic Diagnostic Devices. Its primary akta.pro industry code is HLAHAJAB, Retinal Imaging & OCT Systems (OCT/OCTA, Fundus Cameras, Fluorescein/ICG Angiography), with a secondary code of HLAHAJAC, Visual Field & Functional Vision Testing (Perimetry, ERG/VEP, Contrast Sensitivity). Its NAICS code is 339115 and its SIC code is 3841.